Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review

Overview of attention for article published in Frontiers in endocrinology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 6 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,174 followers.

RT @FrontEndocrinol: New Research: Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abirat…

12 Apr 2023

Reply Repost Favourite

New Research: Efficacy and safety of bipolar androgen therapy in castration-resistant prostate cancer following abiraterone or enzalutamide resistance: A systematic review: Bipolar androgen therapy (BAT) is a new endocrinologic… https://t.co/yagastEOWn #En

11 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.